Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative Therapy for Resectable Pancreatic Adenocarcinoma and Borderline Resectable Pancreatic Adenocarcinoma With Molecular Correlates

NCT02723331 is registered in ClinicalTrials.gov with Academic Thoracic Oncology Medical Investigators Consortium as lead sponsor.

NCT NCT02723331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02723331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative Therapy for Resectable Pancreatic Adenocarcinoma and Borderline Resectable Pancreatic Adenocarcinoma With Molecular Correlates
Lead sponsor
Academic Thoracic Oncology Medical Investigators Consortium
Phase
Phase 2
Overall status
Completed
Start date
December 30, 2016
Completion date
December 28, 2022
Enrollment
48 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas ductal adenocarcinoma, pancreatic adenocarcinoma, pancreatic cancer